Neurobiological Technologies Inc (NASDAQ:NTII) has engaged a financial adviser to explore a sale of the company or its major assets to determine “if there is a transaction more beneficial to our shareholders than a liquidation,” according to its CEO, William Fletcher. We’ve been following NTII (see our post archive here) because it’s trading at a [...]
Posts Tagged ‘Biotechnology Value Fund’
NTII on the block; engages financial adviser
Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Liquidating Value, Neurobiological Technologies Inc (NASDAQ:NTII) on March 31, 2009 | Leave a Comment »
BVF fails to tip AVGN board
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 30, 2009 | 1 Comment »
Biotechnology Value Fund (BVF) failed in its bid to remove Avigen Inc’s (NASDAQ:AVGN) board at Friday’s special meeting of stockholders, despite 58% of stockholders voting in favor of removing the board and only 12% voting in favor of retaining the incumbents. The outcome highlights the difficulties faced by stockholders in selecting rival slates of directors. [...]
AVGN ends merger discussions; terminates CEO and other officers
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 27, 2009 | 3 Comments »
Avigen Inc (NASDAQ:AVGN) has discontinued its merger discussions and terminated its Chief Executive Officer and President, Kenneth Chahine, its Chief Business Officer, Michael Coffee, and its General Counsel, M. Christina Thomson, ahead of the special meeting of stockholders to be held today. Stockholders are to vote on BVF’s proposal to remove the board of AVGN [...]
Catalyst Investment Research on AVGN
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 25, 2009 | Leave a Comment »
Hedge Fund Solutions, which produces The Official Activist Investing Blog, recently announced the launch of a new investment research product, Catalyst Investment Research, which is “dedicated to uncovering undervalued publicly traded companies that could have the potential to generate outsized returns due to an activist investor’s involvement.” Sounds like a good idea to us. Catalyst [...]
AVGN to explore settlement with BVF
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 24, 2009 | Leave a Comment »
Avigen Inc (NASDAQ:AVGN) has authorized its CEO, Dr. Chahine, and RBC to contact Biotechnology Value Fund (BVF) to explore the possibility of negotiating a settlement between BVF and AVGN with respect to BVF’s increased $1.20 per share offer for AVGN. AVGN shareholders are to decide on BVF’s proposal to remove the board of AVGN and [...]
Proxy Governance recommends AVGN shareholders support BVF
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 24, 2009 | Leave a Comment »
Proxy Governance, a proxy advisory firm, has recommended that Avigen Inc (NASDAQ:AVGN) shareholders vote to remove the board of AVGN and elect Biotechnology Value Fund’s (BVF) slate of director nominees at the special meeting of stockholders to be held on March 27, 2009. We’ve been following AVGN (see archived posts here) because it’s a net [...]
AVGN files analysis of MNOV offer
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 24, 2009 | Leave a Comment »
Avigen Inc (NASDAQ:AVGN) has filed its assessment of the cash portion of the MediciNova Inc (NASDAQ:MNOV) proposal. We’ve been following AVGN (see archived posts here) because it’s a net cash stock (i.e. it’s trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology investor BVF has been pushing it [...]
BVF increases tender offer for AVGN to $1.20 per share
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 23, 2009 | 2 Comments »
Biotechnology Value Fund (BVF) has increased its tender offer for Avigen Inc (NASDAQ:AVGN) from $1.00 per share to $1.20 per share contingent on the election of BVF’s nominees to the board of AVGN. We’ve been following AVGN (see archived posts here) because it’s a net cash stock (i.e. it’s trading at less than the value [...]
Empirical Search Strategies supports Biotechnology Value Fund
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 23, 2009 | Leave a Comment »
Wes Gray’s Empirical Search Strategies (ESS) has proclaimed its support for a “downside protection” measure described by the Biotechnology Value Fund (BVF) in the Avigen Inc (NASDAQ:AVGN) proxy fight. ESS is the beneficial owner of approximately 2.3% of AVGN’s outstanding common stock. We’ve been following AVGN (see archived posts here) because it’s a net cash [...]
Here, sir, the people govern?
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 20, 2009 | 5 Comments »
We cast our proxy votes on-line today in support of Biotechnology Value Fund’s (BVF) proposal to remove the board of Avigen Inc (NASDAQ:AVGN). We’ve been following AVGN (see archived posts here) because it’s a net cash stock (i.e. it’s trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology [...]
-
Twitter Updates
- Why Does an Equal-Weighted Portfolio Outperform Market Capitalization- and Price-Weighted Portfolios? wp.me/pnq1T-1td 4 hours ago
- Equal Weight and Fundamental Indexing Beats The Market wp.me/pnq1T-1sV 1 day ago
- Value-Weighted Indexing: The Problem with Active Management wp.me/pnq1T-1sF 2 days ago
- Joel Greenblatt's solution to value investors' behavioral errors wp.me/pnq1T-1s4 3 days ago
- Volatility at World's End: Two Decades of Movement in Markets wp.me/pnq1T-1ry 6 days ago
-
Top Posts
- How to beat the market: Joel Greenblatt's List of Four Things Not To Do
- Value-Weighted Indexing: The Problem with Active Management
- Equal Weight and Fundamental Indexing Beats The Market
- Joel Greenblatt's solution to value investors' behavioral errors
- Why Does an Equal-Weighted Portfolio Outperform Market Capitalization- and Price-Weighted Portfolios?
Seeking Alpha Contributor
Blogroll
- Abnormal Returns
- Breakout Performance
- Calculated Risk
- Cheap Stocks
- Compounding Machines
- Controlled Greed
- Dealbook
- Distressed Debt Investing
- Empirical Finance Research
- footnoted.org
- Graham NCAV Screen
- GuruFocus
- Hedge Fund Jobs
- Insider Monkey
- Manual of Ideas
- Official Activist Investing Blog
- Old School Value
- Oozing Alpha
- Shadowstock blog
- Simoleon Sense
- Stingy Investor
- Street Capitalist
- SumZero
- Value Investing Blog
- Value Uncovered
- Yes and Not Yes
Archives
- May 2012
- April 2012
- February 2012
- December 2011
- November 2011
- July 2011
- June 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
